AstraZeneca trial results raise questions for U.S. health officials

The National Institute of Allergy and Infectious diseases is raising concerns about AstraZeneca's COVID-19 vaccine trial results, which included some apparently outdated information. Tanya Rivero spoke with Dr. Eric Cioe-Peña, an emergency room physician and director of Global Health at Northwell Health, about the significance.